Last update Dec. 30, 2021
Very Low Risk
A second generation antihistamine, derived from piperazine and hydroxyzine metabolite, with minimal sedative effects and very low toxicity even at high doses. Indicated in allergic rhinitis and chronic urticaria. Oral administration in a single daily dose.
It is excreted in breast milk in clinically insignificant amounts (Wilkerson 2021). Their pharmacokinetic data (high volume of distribution and high percentage of plasma protein binding) probably explain the negligible excretion observed in breast milk.
No problems in the short or long term have been observed in infants whose mothers have taken it.(Wilkerson 2021, Gashlin 2016, Westermann 2012)
Cetirizine has been used in nursing mothers to treat persistent neuropathic breast pain.(Muddana 2018)
The British Society for Allergy and Clinical Immunology and other experts consider it safe during breastfeeding.(Hale, Middleton 2020, Briggs 2015, Schaefer 2015, Butler 2014, Powell 2007)
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2006 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM